Skip to main content
Premium Trial:

Request an Annual Quote

Evonik, Genedata Extend Software, Services Agreement

NEW YORK (GenomeWeb News) – Evonik, a specialty chemicals firm, has extended an existing collaboration with Genedata allowing it to continue to use Genedata Selector, the company's software for managing and analyzing strain information, and in addition, to take advantage of Genedata's consulting and specialized IT services.

Evonik has been using the Selector software to manage, visualize, and analyze genomic data from production strains in order to identify mutations and explore complex genotype-phenotype relationships. These strains are used to produce bio-based chemicals, nutritional proteins, food and feed additives, and cosmetics ingredients.

Under the new agreement, Evonik will now also use Genedata's data analysis consulting such as proprietary genome annotations, production strain comparisons, cellular signaling network reconstructions for proprietary strains, and statistical expression analysis reports. Evonik will also have access to IT services such as hosting and remote server maintenance, software and database integration services, and data migration and integration services.

According to Genedata, these services will help Evonik eliminate resource bottlenecks, provide cost-effective support for projects, and deliver results quickly and efficiently.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.